Lifeward CEO Larry Jasinski Plans to Retire After 13 Years
CEO announces transition plans after significant leadership in the paralyzed community Lifeward (formerly ReWalk Robotics) CEO Larry Jasinski announced his plans to retire after 13
CEO announces transition plans after significant leadership in the paralyzed community Lifeward (formerly ReWalk Robotics) CEO Larry Jasinski announced his plans to retire after 13
Revolutionizing brain-computer interface technology with a non-surgical approach Subsense, a Brain-Computer Interface (BCI) company, has officially emerged from stealth mode after securing $17 million in
Milestone in clinical study for chronic migraine treatment Salvia BioElectronics has announced its first migraine therapy implant in The Netherlands at Erasmus MC in Rotterdam.
STIMULUS trial demonstrates improvement in hemodynamic performance in mechanically ventilated patients Lungpacer Medical today unveiled promising results from its Phase 1 STIMULUS clinical study that
Positioning for Leadership in Hypertension Treatment Boston Scientific has announced a $540 million acquisition of SoniVie, maker of the Tivus ultrasound-based renal denervation (RDN) system.
Company President Randy Clark to take over COO responsibilities in April 2025 Vicarious Surgical (NYSE: RBOT) announced that John Mazzola, its chief operating officer (COO),
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
